Swallowing Scars: Hidden Dysphagia Lingers in Cancer Survivors Years After Treatment

Surviving oropharyngeal cancer is often celebrated as the end of a long and punishing journey, but for many patients the hardest part begins after the last radiation session. A new cross-sectional study published in Supportive Care in Cancer has shed light on a problem that quietly erodes the quality of life of disease-free survivors: persistent swallowing dysfunction, known medically as dysphagia. The research, led by Daniela Oliveira Vieira and colleagues from Portuguese research and clinical institutions including Rede de Investigação em Saúde and the Portuguese Oncology Institute of Porto, examined 38 survivors of oropharyngeal cancer who had been treated with chemoradiotherapy and were free of disease at the time of assessment. What the team found is a striking mismatch between what high-tech instruments can see inside a patient’s throat and what those patients actually feel, a discrepancy with major implications for how follow-up care should be designed.

Chemoradiotherapy, the simultaneous delivery of chemotherapy and radiation, has become a cornerstone treatment for locally advanced oropharyngeal tumors, which arise in the tonsils, base of tongue, and surrounding throat tissues. The approach can be organ-preserving and highly effective at controlling disease, but it comes at a physiological cost. Radiation fields inevitably overlap with muscles, nerves, and mucosal surfaces that orchestrate the deceptively complex act of swallowing, a behavior that requires more than thirty paired muscles to contract in precise sequence within roughly one second. Fibrosis, neuromuscular damage, and loss of salivary function can leave survivors with a throat that moves stiffly and inefficiently, sometimes for the rest of their lives. Previous research has linked severe dysphagia in head and neck cancer patients not only to malnutrition and social isolation but also to worse survival itself, making the problem far more than a comfort issue.

To capture the true scope of the problem, the Portuguese team deployed two fundamentally different kinds of measurement. The first was flexible endoscopic evaluation of swallowing, or FEES, an instrumental technique in which a thin endoscope is passed through the nose to the pharynx, allowing clinicians to watch swallowing physiology directly and in real time. FEES reveals objective phenomena: whether food or liquid penetrates the laryngeal vestibule, whether material is aspirated below the vocal folds, how much residue coats the pharyngeal walls after each swallow, and how many repeat swallows a patient needs to clear a bolus of solid food. The second approach relied on patient-reported outcome measures, or PROMs, using three validated questionnaires: the EORTC QLQ-C30, a general cancer quality-of-life instrument; the EORTC QLQ-H&N43, a head-and-neck-specific module; and the SWAL-QOL, a dedicated swallowing quality-of-life tool that probes the burden dysphagia places on eating, social life, and emotional wellbeing.

The instrumental findings were sobering. FEES identified frequent swallowing impairments across the cohort, with pharyngeal residue emerging as a particularly dominant problem. In practical terms, after each swallow, food particles and liquid remained coating the throat rather than being cleared into the esophagus, a phenomenon that is not merely uncomfortable but dangerous, because residue can slip into the airway after the swallow is over, in what clinicians call post-swallow aspiration. The endoscopic evaluations also documented an increased number of swallows required to clear solid consistencies, reflecting reduced swallowing efficiency, as well as penetration-aspiration events in which material entered or passed below the level of the larynx. These are the classic physiological signatures of radiation-induced pharyngeal dysfunction, and their frequency in disease-free survivors underscores how durable the damage can be long after treatment ends.

The questionnaire data told an equally important story from the patient’s side of the experience. All three instruments revealed substantial dysphagia-related burden, but the SWAL-QOL stood out by identifying the highest proportion of altered results among the survivors. This finding makes intuitive sense once the tool’s design is considered: because SWAL-QOL was built specifically to measure the consequences of oropharyngeal dysphagia, it asks about domains the generic cancer instruments barely touch, including the fear of choking, the embarrassment of eating in public, the fatigue of prolonged meals, and the loss of pleasure associated with food. For survivors whose tumors originated in the very structures used for eating and speaking, these dimensions are not peripheral; they define daily life. A survivor who can technically swallow but dreads every meal carries a burden that a clinical chart may never record.

Perhaps the most scientifically consequential result of the study lies in what the researchers did not find. When they explored the associations between objective FEES findings and the quality-of-life domains captured by the questionnaires, using correlation and comparative analyses, they observed some connections between the two worlds. Yet no consistent one-to-one relationship emerged between physiological impairment and patient-reported burden. In other words, a survivor whose endoscopy shows significant residue or aspiration may report only modest distress, while another with comparatively subtle physiological findings may describe a devastating impact on eating and social functioning. This decoupling of mechanism from experience is not a flaw in either measurement approach; it is a fundamental property of how chronic illness is lived, shaped by adaptation, compensation, expectations, and psychological resilience.

The study’s authors frame this as evidence that FEES and PROMs capture complementary dimensions of dysphagia rather than redundant ones. FEES maps the biomechanics: the safety of the swallow, its efficiency, and the temporal physiology of the pharyngeal phase. PROMs map the functional and psychosocial fallout: whether the patient can enjoy a restaurant meal, maintain weight, and feel like a full participant in family life. Neither alone provides a complete clinical picture. A follow-up program built solely on instrumental assessments risks dismissing patients whose suffering is real but invisible to the endoscope, while a program built solely on questionnaires risks missing silent aspiration, the dangerous scenario in which material enters the airway without triggering any cough or sensation, quietly predisposing patients to pneumonia.

These findings arrive amid a broader shift in oncology toward routine collection of patient-reported outcomes during and after treatment. Systematic reviews have identified PROMs as valuable tools for surveillance of physical and emotional symptoms in head and neck cancer populations, and prior studies have repeatedly noted that patient-assessed symptoms can be poor predictors of objective findings in irradiated pharyngeal cancer patients. The Portuguese study adds weight to this literature by demonstrating the same discordance in a carefully defined group: disease-free survivors, assessed with a validated Portuguese version of SWAL-QOL, paired with structured endoscopic evaluation. The convergence of independent lines of evidence strengthens the argument that dual assessment should become standard practice rather than an optional refinement.

The clinical implications are concrete. For survivors of oropharyngeal cancer treated with chemoradiotherapy, long-term follow-up should ideally combine periodic instrumental swallowing evaluation with validated questionnaires, so that rehabilitation can be targeted to the specific physiology found on FEES while counseling and psychosocial support are guided by what patients actually report. Swallowing therapy, dietary modification, and prophylactic exercise programs exist and can help, but they can only be deployed rationally when the full picture of a patient’s dysfunction is known. The study’s cross-sectional design, with 38 participants, means the findings describe a snapshot rather than a trajectory, and the authors themselves position the work as exploratory; larger longitudinal studies will be needed to track how the relationship between physiology and perception evolves over the years after treatment.

Still, the central message resonates far beyond this single cohort. Modern cancer medicine has become extraordinarily good at measuring tumors, but measuring the aftermath of cure remains an inexact science. For the growing population of oropharyngeal cancer survivors, many of them relatively young and facing decades of life after treatment, the difference between a cure and a good life often comes down to functions as mundane and as profound as swallowing a meal without fear. This study reminds clinicians, researchers, and patients alike that the throat seen through an endoscope and the meal experienced at a family table are two different territories, and that good survivorship care requires a map of both.

Subject of Research: Swallowing dysfunction and quality of life in oropharyngeal cancer survivors after chemoradiotherapy

Article Title: Patient-reported swallowing burden and FEES findings in disease-free oropharyngeal cancer survivors after chemoradiotherapy

Article References: Vieira, D. O., Barreira, S., Dinis-Ribeiro, M., & Monteiro, E. (2026). Patient-reported swallowing burden and FEES findings in disease-free oropharyngeal cancer survivors after chemoradiotherapy. Supportive Care in Cancer, 34(10), Article 1071. https://doi.org/10.1007/s00520-026-11307-4

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11307-4

Keywords: oropharyngeal cancer, dysphagia, chemoradiotherapy, FEES, patient-reported outcomes, SWAL-QOL, quality of life, head and neck cancer, supportive care, cancer survivorship, swallowing rehabilitation, EORTC questionnaires